Valentis Laboratories Profile
Key Indicators
- Authorised Capital ₹ 8.00 Cr
as on 17-07-2024
- Paid Up Capital ₹ 3.10 Cr
as on 17-07-2024
- Company Age 25 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 35.76 Cr
as on 17-07-2024
- Satisfied Charges ₹ 8.99 Cr
as on 17-07-2024
- Revenue 32.74%
(FY 2023)
- Profit 11.46%
(FY 2023)
- Ebitda -4.45%
(FY 2023)
- Net Worth 7.63%
(FY 2023)
- Total Assets 41.08%
(FY 2023)
About Valentis Laboratories
The Corporate was formerly known as Valentis Pharma Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 8.00 Cr and a paid-up capital of Rs 3.10 Cr.
The company currently has active open charges totaling ₹35.76 Cr. The company has closed loans amounting to ₹8.99 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sriramakrishna Pratiwada, Partiwada Rani, Ravi Prativada, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24110TG1999PTC031736
- Company No.
031736
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 May 1999
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Sangareddy, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Valentis Laboratories Private Limited offer?
Valentis Laboratories Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Anti Infective API, Organic and Inorganic Solvents, Ketones, Cardiovascular Drugs & Medication, Diabetes Medicine.
Who are the key members and board of directors at Valentis Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sriramakrishna Pratiwada  | Managing Director | 19-May-2009 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ravi Prativada | Director | 14-Mar-2023 | Current |
| Partiwada Rani | Director | 01-Apr-2000 | Current |
| Devarapu Deep | Director | 05-Apr-2018 | Current |
| Pratiwada Prasad | Director | 11-Sep-2018 | Current |
Financial Performance and Corporate Structure Insights of Valentis Laboratories.
Valentis Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 32.74% increase. The company also saw a substantial improvement in profitability, with a 11.46% increase in profit. The company's net worth moved up by a moderate rise of 7.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Valentis Laboratories?
In 2023, Valentis Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
_PRIVATE_LIMITED.webp)
Terratech Chemicals (India) Private LimitedActive 32 years 8 monthsRavi Prativada and Pratiwada Prasad are mutual person
Karan Intermediates Private LimitedActive 30 years 5 monthsSriramakrishna Pratiwada, Ravi Prativada and 1 more are mutual person
Gingurthy Minerals LlpActive 1 year 8 monthsSriramakrishna Pratiwada and Pratiwada Prasad are mutual person
- Pashamylaram Common Infrastructure Private LimitedActive 14 years 11 months
Sriramakrishna Pratiwada is a mutual person
- Pashamylaram Cetp Private LimitedActive 2 years 10 months
Sriramakrishna Pratiwada is a mutual person
- 12 Cube Enterprises Private LimitedActive 11 years 9 months
Ravi Prativada and Pratiwada Prasad are mutual person
_PRIVATE_LIMITED.webp)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 30 Jun 2023 | ₹3.00 M | Open |
Axis Bank Limited Creation Date: 12 Dec 2022 | ₹6.57 M | Open |
Axis Bank Limited Creation Date: 17 Aug 2020 | ₹3.80 Cr | Open |
How Many Employees Work at Valentis Laboratories?
Valentis Laboratories has a workforce of 108 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Valentis Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Valentis Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
